Scarica l'app Stockscreener
0.89
33.58%
-0.45
Pre-mercato:
.89
Precedente Chiudi:
$1.34
Aprire:
$0.975
Volume 24 ore:
1.57M
Relative Volume:
3.35
Capitalizzazione di mercato:
$19.78M
Reddito:
$411.00K
Utile/perdita netta:
$-4.85M
Rapporto P/E:
-2.0227
EPS:
-0.44
Flusso di cassa netto:
$-4.88M
1 W Prestazione:
-18.35%
1M Prestazione:
-16.04%
6M Prestazione:
-8.86%
1 anno Prestazione:
-60.27%
Intervallo 1D:
$0.8212
$1.00
Intervallo di 1 settimana:
$0.8212
$1.44
Portata 52W:
$0.7749
$2.43
Lexaria Bioscience Corp Stock (LEXX) Company Profile
Nome
Lexaria Bioscience Corp
Settore
Industria
Telefono
250-765-6424
Indirizzo
100 - 740 MCCURDY ROAD, KELOWNA
Confronta LEXX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LEXX
Lexaria Bioscience Corp
|
0.89 | 29.78M | 411.00K | -4.85M | -4.88M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lexaria Bioscience Corp Borsa (LEXX) Ultime notizie
Lexaria Bioscience Secures $3.5 Million in Capital Through Registered Direct Offering - citybuzz
Lexaria Bioscience raises $3.5 million in at-market offering By Investing.com - Investing.com Nigeria
Lexaria Bioscience raises $3.5 million in at-market offering - Investing.com India
Lexaria Bioscience Secures $3.5 Million in Direct Offering to Boost R&D - TipRanks
Lexaria Bioscience plummets on $3.5M equity offering - MSN
Lexaria Bioscience Corp. (LEXX) Drops 28% in Pre-market: Following Direct Offering Announcement - Stocks Telegraph
LEXX Appoints H.C. Wainwright & Co. as Exclusive Placement Agent - GuruFocus
Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Investing News Network
Lexaria Bioscience stock plunges after $3.5M at-the-market offering - Investing.com
Lexaria (NASDAQ: LEXX) prices $3.5M direct stock offering, adds 5-year warrants - Stock Titan
Lexaria Bioscience (NASDAQ:LEXX) Downgraded by Wall Street Zen to “Sell” - Defense World
How Lexaria Bioscience Corp. Equity Warrant stock performs in high volatility markets2025 Support & Resistance & Intraday High Probability Setup Alerts - Newser
How Lexaria Bioscience Corp. Equity Warrant stock compares to growth peersJuly 2025 Setups & Verified Technical Signals - Newser
Is Lexaria Bioscience Corp. stock a safe haven assetTake Profit & Risk Adjusted Buy and Sell Alerts - Newser
Lexaria Bioscience (LEXX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Lexaria Bioscience Corp. (NASDAQ:LEXX): Are Analysts Optimistic? - Yahoo Finance
Lexaria Bioscience (NASDAQ:LEXX) Stock Rating Upgraded by Wall Street Zen - Defense World
Lexaria Bioscience Corp. SEC 10-K Report - TradingView
Lexaria Bioscience : Annual Report for Fiscal Year Ending 08-31, 2025 (Form 10-K) - marketscreener.com
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended - Investing News Network
Lexaria Bioscience Corp. Reports Earnings Results for the Full Year Ended August 31, 2025 - marketscreener.com
Lexaria Bioscience Corp Stock Analysis and ForecastVolatility Index Analysis & Unlock Long-Term Capital Growth Ideas - earlytimes.in
Lexaria Bioscience Corp. Auditor Raises 'Going Concern' Doubt - marketscreener.com
NexMetals Mining (NASDAQ:NEXM) vs. Lexaria Bioscience (OTCMKTS:LXRP) Financial Survey - Defense World
S&P 500, NASDAQ and Dow rise as Wall Street ends volatile week on higher side: M-tron Industries gains nea - The Economic Times
Lexaria Bioscience Corp. (LEXX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What catalysts could drive Lexaria Bioscience Corp. stock higher2025 Momentum Check & Weekly Chart Analysis and Guides - newser.com
Will Lexaria Bioscience Corp. stock gain from lower inflationQuarterly Earnings Report & Fast Exit/Entry Strategy Plans - newser.com
Will Lexaria Bioscience Corp. Equity Warrant stock deliver long term returns2025 Market Trends & Verified Trade Idea Suggestions - newser.com
Key metrics from Lexaria Bioscience Corp.’s quarterly dataPortfolio Return Summary & Precise Entry and Exit Recommendations - newser.com
Can Lexaria Bioscience Corp. Equity Warrant stock sustain institutional interestMarket Movement Recap & AI Based Buy and Sell Signals - newser.com
Does Lexaria Bioscience Corp. stock trade at a discount to peers2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
Is Lexaria Bioscience Corp. stock a top momentum playWeekly Trend Recap & Weekly High Potential Alerts - newser.com
Will Lexaria Bioscience Corp. stock deliver consistent dividendsMarket Performance Recap & Expert Verified Movement Alerts - newser.com
Has Lexaria Bioscience Corp. found a price floorJuly 2025 Gainers & Technical Entry and Exit Tips - newser.com
How strong is Lexaria Bioscience Corp. Equity Warrant stock balance sheetJuly 2025 Market Mood & Weekly Breakout Stock Alerts - newser.com
Will Lexaria Bioscience Corp. stock maintain momentum in 2025Trade Analysis Report & Short-Term Trading Opportunity Alerts - newser.com
How to escape a deep drawdown in Lexaria Bioscience Corp. Equity WarrantMarket Risk Analysis & Reliable Price Action Trade Plans - newser.com
How to manage a losing position in Lexaria Bioscience Corp. Equity WarrantSell Signal & Daily Growth Stock Investment Tips - newser.com
How institutional buying supports Lexaria Bioscience Corp. stockAnalyst Upgrade & Accurate Intraday Trade Tips - newser.com
Is Lexaria Bioscience Corp. Equity Warrant stock attractive for passive investors - newser.com
What makes Lexaria Bioscience Corp. Equity Warrant stock attractive to growth fundsBull Run & Risk Managed Trade Strategies - newser.com
Analyzing Lexaria Bioscience Corp. Equity Warrant with risk reward ratio chartsWeekly Risk Report & AI Powered Buy and Sell Recommendations - newser.com
How Lexaria Bioscience Corp. stock performs in rising dollar environment2025 Risk Factors & Consistent Profit Trading Strategies - newser.com
Lexaria Bioscience Corp Azioni (LEXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):